New hope for HIV patients: study targets smoking and drinking together
NCT ID NCT06790342
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 22 times
Summary
This study looks at whether intensive counseling, with or without a medication called cytisine, can help people with HIV quit smoking and cut down on heavy drinking. The trial will enroll 300 adults in Nairobi, Kenya, who smoke and drink heavily. The goal is to find better ways to manage these health risks in a resource-limited setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mathari National Teaching and Referral Hospital
Nairobi, Kenya
-
Riruta Health Centre
Nairobi, Kenya
Conditions
Explore the condition pages connected to this study.